Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssentra Regulatory News (ESNT)

Share Price Information for Essentra (ESNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 171.60
Bid: 171.40
Ask: 171.60
Change: 0.40 (0.23%)
Spread: 0.20 (0.117%)
Open: 171.00
High: 172.00
Low: 168.00
Prev. Close: 171.20
ESNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of New Chief Executive

31 Oct 2016 07:01

RNS Number : 8368N
Essentra plc
31 October 2016
 

31 October 2016

 

 

ESSENTRA PLC

 

A leading global provider of essential components and solutions

APPOINTMENT OF NEW CHIEF EXECUTIVE

Further to the announcement of 29 July 2016, the Board of Essentra plc ("Essentra" or "the Company") today announces the appointment of Paul Forman to the Board with effect from 1 January 2017, to succeed Colin Day as Chief Executive. Colin will stand down as Chief Executive with effect from 31 December 2016, and will retire from the Board and the Company following the Company's 2016 Annual General Meeting on 20 April 2017.  

Paul brings a wide range of operational and strategic experience in international manufacturing to Essentra, including most recently at Coats Group plc ("Coats") - the world's leading industrial thread manufacturer - where he has been Group Chief Executive since January 2010. Before joining Coats, Paul was Group Chief Executive of the global performance materials business Low & Bonar PLC, prior to which he was Managing Director of Unipart International, the leading European automotive aftermarket supplier. Since January 2015, Paul has also served as a Non-Executive Director of Tate & Lyle plc, and was previously a Non-Executive Director of Brammer plc from 2006 to 2010.

Commenting on today's announcement, Paul Lester, Non-Executive Chairman, said:

"On behalf of the Board, I would like to thank Colin for his outstanding contribution to the development and performance of Essentra over the last five years, and for his commitment and dedication during that time. Under his stewardship, both revenue and profits have more than doubled and, through rebranding the Company to Essentra, he led the creation of a single, unified organisation which is better able to maximise available growth opportunities and leverage its skills as a leading global supplier of essential components. Colin will work closely with Paul to ensure a smooth transition, and we wish him all the very best as he pursues his intention of focusing increasingly on Non-Executive activities.

I am delighted that Paul Forman is joining Essentra as Chief Executive. Paul brings a proven track record of international experience at the highest level - notably at Coats, where he has overseen company rationalisation as well as growth through acquisition, instigated and delivered a clear vision and corporate strategy, driven material improvements in financial performance and built the momentum to position the business as the innovative and global industry leader it is today. His prior experience as an adviser in strategy and acquisitions will also prove extremely relevant in the future evolution of Essentra. My fellow Board members and I look forward to working with him."

Paul Forman added:

"I am excited to be joining Essentra, and very much look forward to working with my new colleagues to build on the success which the Company has achieved to date, with a view to delivering sustainable long-term shareholder value."

Paul Forman has advised the Company that no other details are required to be disclosed under Listing Rule 9.6.13.

Market Abuse Regulation Statement

This announcement contains inside information.

Enquiries

Essentra plc

Joanna Speed, Corporate Affairs Director

Tel: +44 (0)1908 359100

Ogilvy PR London

James Stewart

Tel: +44 (0) 7342 068609

E-mail: james.stewart@ogilvy.com

 

Notes to Editors

About Paul Forman

 

2010 to date Group Chief Executive, Coats Group plc

2002 - 2009 Group Chief Executive, Low & Bonar PLC

1998 - 2002 Managing Director, Unipart International

1994 - 1998 Director of Strategy and Head of Asia, Caradon

1989 - 1994 The Kalchas Group

1988 - 1989 BZW Corporate Finance

1986 - 1988 Bain & Company

 

 

About Essentra plc

Essentra plc is a FTSE 250 company and a leading global provider of essential components and solutions. Essentra focuses on the light manufacture and distribution of high volume, enabling components which serve customers in a wide variety of end-markets and geographies.

Component Solutions

The Components business is a global market leading manufacturer and distributor of plastic injection moulded, vinyl dip moulded and metal items. Operating units in 29 countries serve a very broad industrial base of customers with a rapid supply of products for a variety of applications in industries such as equipment manufacturing, automotive, fabrication, electronics and construction.

The Pipe Protection Technologies business specialises in the manufacture of high performance innovative products from commodity resins to engineering-grade thermoplastics and polymer alloys for use in a range of end-markets. Locations in four countries, combined with a wide distributor network, serve customers around the world.

Essentra Extrusion is a leading custom profile extruder located in the Netherlands which offers a complete design and production service. One of the first companies to extrude plastics in 1956, Essentra is now one of Europe's most advanced suppliers of co-extrusion and tri-extrusion to all branches of industry.

The Security business has access to a wide portfolio of products and services, including printers, software and consumables from leading manufacturers.

Health & Personal Care Packaging

A leading global provider of packaging and authentication solutions to a diversified blue-chip customer base in the pharmaceutical, health & personal care, consumer and specialist packaging sectors. The business focuses on delivering value-adding innovation, quality and service through the provision of a wide range of printed products and solutions, including cartons, tapes, leaflets, foils, labels and authentication solutions.

The Speciality Tapes business has expertise in coating multiple adhesive systems in numerous technologies. With close to 3,000 adhesive products available for same-day shipping, Essentra's products can meet all high performance needs, from foam, magnetic, finger lift and acrylic high bond tapes to hook and loop and non-skid foam.

Filtration Products

Essentra Filter Products is the only global independent cigarette filter supplier. The nine worldwide locations, including a dedicated Technology Centre supported by three regional development facilities, provide a flexible infrastructure strategically positioned to serve the tobacco industry. The business supplies a wide range of value-adding high quality innovative filters, packaging solutions to the roll your own segment and analytical laboratory services for ingredient measurement to the industry.

Essentra Porous Technologies is a leading developer and manufacturer of custom fluid handling components, engineered from a portfolio of technologies that includes bonded and non-woven fibre, polyurethane foam and porous plastics. Representing innovations used in healthcare, consumer and industrial applications, its enabling components are found in a wide range of products from medical diagnostics tests to advanced wound care pads, inkjet printer cartridges, writing instruments, clean room wipes and air fresheners.

Headquartered in the United Kingdom, Essentra's global network extends to 33 countries and includes c. 9,000 employees, 53 principal manufacturing facilities, 64 sales & distribution operations and 5 research & development centres. For further information, please visit www.essentraplc.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGRBDGGGXBGLB
Date   Source Headline
23rd Apr 20241:57 pmRNSDirector/PDMR Shareholding
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20242:28 pmRNSDirector/PDMR Shareholding
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20241:35 pmRNSDirector/PDMR Shareholding
5th Apr 20241:35 pmRNSDirector/PDMR Shareholding
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20242:08 pmRNSDirector/PDMR Shareholding
4th Apr 202411:00 amRNSNotice of AGM
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 202411:26 amRNSTransaction in Own Shares
2nd Apr 20242:51 pmRNSDirector/PDMR Shareholding
2nd Apr 20247:00 amRNSTotal Voting Rights
28th Mar 20244:18 pmRNSPublication of 2023 Annual Report
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSDirectorate Change
19th Mar 20247:00 amRNSResults for the Full Year Ended 31 December 2023
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:53 amRNSTotal Voting Rights
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSNotice of Full Year 2023 Results
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSSBTi approval for near-term and net-zero targets
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.